MDMA for PTSD granted Expanded Access by FDA, patient treatments begin

by EmpathiCSubstanceS | Feb 8, 2020 | Addiction, Alcoholism, Anxiety, Bipolar Disorder, Depression, Kambo

Marking an impressive milestone in the development of MDMA-assisted psychotherapy for PTSD, the U.S. Food and Drug Administration (FDA) has approved the treatment for Expanded Access, allowing certain patients access to the therapy before full market approval is...

Release the Kratom: Inside America’s Hottest New Drug Culture

by EmpathiCSubstanceS | Feb 8, 2020 | Addiction, Alcoholism, Bipolar Disorder, Depression, PTSD

Many use kratom to quit opioids; others just want to get high. There’s a push to regulate the plant-derived drug—but experts disagree on its safety. By her mid-20s, Faith Day was out of jail but homeless. She was also addicted to a substance now too legally...

Using LSD, MDMA and Psilocybin to Treat Mental Health

by EmpathiCSubstanceS | Feb 8, 2020 | Addiction, Alcoholism, Anxiety, Bipolar Disorder, Depression

While psychedelic drugs such as LSD, psilocybin, and DMT are most commonly associated with recreational highs and headtrips, a groundswell of academic opinion suggests that the substances could be utilized to serve a raft of therapeutic benefits as well. In Australia,...

The World’s First Clinical Trials on Microdosing LSD and Psilocybin Are Coming

by EmpathiCSubstanceS | Feb 8, 2020 | Addiction, Alcoholism, Anxiety, Depression

Does microdosing actually do anything, or is it a posh urban myth? A research team in New Zealand is about to find out in the world’s first randomized, controlled clinical trial. LSD has largely been ignored while the world gushes over legal weed and...

Psilocybin for major depression granted Breakthrough Therapy by FDA

by EmpathiCSubstanceS | Nov 25, 2019 | Depression

The US Food and Drug Administration (FDA) has granted psilocybin therapy a Breakthrough Therapy designation for the second time in a year, this time with a view on accelerating trials testing its efficacy treating major depressive disorder (MDD). Back in late...

Active Ingredient in Shrooms Could ‘Reset’ Brains of Depressed People

by EmpathiCSubstanceS | Nov 25, 2019 | Depression

Psilocybin, the psychoactive compound found naturally in “magic mushrooms,” has shown promising results in treating anxiety and depression. A recently published study reinforces that potential, demonstrating that depressed patients treated with psilocybin...